The Use of Ketamine for the Treatment of Anhedonia in Depression

Athira KV, Bandopadhyay S, Samudrala PK, Naidu V, Lahkar M, Chakravarty S. An overview of the heterogeneity of major depressive disorder: current knowledge and future prospective. Curr Neuropharmacol. 2020;18(3):168–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonanni L, Gualtieri F, Lester D, Falcone G, Nardella A, Fiorillo A, et al. Can anhedonia be considered a suicide risk factor? A review of the literature. Medicina. 2019;55(8):458.

Article  PubMed  PubMed Central  Google Scholar 

Guineau MG, Ikani N, Rinck M, Collard R, Van Eijndhoven P, Tendolkar I, et al. Anhedonia as a transdiagnostic symptom across psychological disorders: a network approach. Psychol Med. 2023;53(9):3908–19.

Article  PubMed  Google Scholar 

Šagud M, Šimunović Filipčić I, Jakšić NJ, Šimunić LŠ, Jezernik D, Tudor L, et al. Anhedonia in schizophrenia: Mini-review. Psychiatr Danub. 2019;31(suppl 2):143–7.

PubMed  Google Scholar 

Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. Am Psychiatric Assoc. 2010; p. 748–51.

Serretti A. Anhedonia and depressive disorders. Clin Psychopharmacol Neurosci. 2023;21(3):401–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Treadway MT, Zald DH. Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev. 2011;35(3):537–55.

Article  PubMed  Google Scholar 

Barbano MF, Cador M. Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology. 2007;191(3):497–506.

Article  CAS  PubMed  Google Scholar 

Cao B, Park C, Subramaniapillai M, Lee Y, Iacobucci M, Mansur RB, et al. The efficacy of vortioxetine on anhedonia in patients with major depressive disorder. Front Psych. 2019;10: 434932.

Google Scholar 

Mazza M, Squillacioti MR, Pecora RD, Janiri L, Bria P. Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients. Psychiatry Res. 2009;165(1):193–6.

Article  CAS  PubMed  Google Scholar 

Whitton AE, Pizzagalli DA. Anhedonia in depression and bipolar disorder. Curr Top Behav Neurosci. 2022; 58: p. 111–27.

Liang S, Wu Y, Hanxiaoran L, Greenshaw AJ, Li T. Anhedonia in depression and schizophrenia: brain reward and aversion circuits. Neuropsychiatr Dis Treat. 2022;18:1385.

Article  PubMed  PubMed Central  Google Scholar 

Craske MG, Meuret AE, Ritz T, Treanor M, Dour H, Rosenfield D. Positive affect treatment for depression and anxiety: A randomized clinical trial for a core feature of anhedonia. J Consult Clin Psychol. 2019;87(5):457.

Article  PubMed  Google Scholar 

Taylor CT, Hoffman SN, Khan AJ. Anhedonia in anxiety disorders. Anhedonia Preclin Transl Clin Integr. 2022;58:201–18.

Turner V, Husain M. Anhedonia in neurodegenerative diseases. Anhedonia Preclin Transl Clin Integr. 2022; p. 255-77.

Saz P, López-Antón R, Dewey M, Ventura T, Martin A, Marcos G, et al. Prevalence and implications of psychopathological non-cognitive symptoms in dementia. Acta Psychiatr Scand. 2009;119(2):107–16.

Article  CAS  PubMed  Google Scholar 

Stull SW, Bertz JW, Epstein DH, Bray BC, Lanza ST. Anhedonia and substance use disorders by type, severity, and with mental health disorders. J Addict Med. 2022;16(3): e150.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ceres R, Cascino G. Anhedonia in anorexia nervosa: a narrative review. J Psychopathol. 2024;30:44-52

Dolan SC, Khindri R, Franko DL, Thomas JJ, Reilly EE, Eddy KT. Anhedonia in eating disorders: a meta-analysis and systematic review. Int J Eat Disord. 2022;55(2):161–75.

Article  PubMed  Google Scholar 

Downar J, Geraci J, Salomons TV, Dunlop K, Wheeler S, McAndrews MP, et al. Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biol Psychiat. 2014;76(3):176–85.

Article  PubMed  Google Scholar 

Winer ES, Jordan DG, Collins AC. Conceptualizing anhedonias and implications for depression treatments. Psychol Res Behav Manag. 2019;12:325–35.

Khazanov GK, Forbes CN, Dunn BD, Thase ME. Addressing anhedonia to increase depression treatment engagement. Br J Clin Psychol. 2022;61(2):255–80.

Article  PubMed  Google Scholar 

Spijker J, Bijl R, De Graaf R, Nolen W. Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: Results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand. 2001;103(2):122–30.

Article  CAS  PubMed  Google Scholar 

McIntyre RS, Woldeyohannes HO, Soczynska JK, Maruschak NA, Wium-Andersen IK, Vinberg M, et al. Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative Project. CNS Spectr. 2016;21(5):362–6.

Article  PubMed  Google Scholar 

Auerbach RP, Pagliaccio D, Kirshenbaum JS. Anhedonia and suicide. Curr Top Behav Neurosci. 2022;58:443–64.

Gillissie ES, Le GH, Rhee TG, Cao B, Rosenblat JD, Mansur RB, et al. Evaluating Anhedonia as a risk factor in suicidality: a meta-analysis. J Psychiatric Res. 2023. 158: p. 209-215

Ducasse D, Dubois J, Jaussent I, Azorin JM, Etain B, Gard S, et al. Association between anhedonia and suicidal events in patients with mood disorders: a 3-year prospective study. Depress Anxiety. 2021;38(1):17–27.

Article  PubMed  Google Scholar 

Ducasse D, Loas G, Dassa D, Gramaglia C, Zeppegno P, Guillaume S, et al. Anhedonia is associated with suicidal ideation independently of depression: a meta-analysis. Depress Anxiety. 2018;35(5):382–92.

Article  PubMed  Google Scholar 

Poletti M, Pelizza L, Loas G, Azzali S, Paterlini F, Garlassi S, et al. Anhedonia and suicidal ideation in young people with early psychosis: further findings from the 2-year follow-up of the ReARMS program. Psychiatry Res. 2023;323: 115177.

Article  PubMed  Google Scholar 

Bonanni L, Gualtieri F, Lester D, Falcone G, Nardella A, Fiorillo A, et al. Can anhedonia be considered a suicide risk factor? A review of the literature. Medicina (Kaunas). 2019;55(8).

Jahn DR, Bennett ME, Park SG, Gur RE, Horan WP, Kring AM, et al. The interactive effects of negative symptoms and social role functioning on suicide ideation in individuals with schizophrenia. Schizophr Res. 2016;170(2–3):271–7.

Article  PubMed  Google Scholar 

Loas G, Azi A, Noisette C, Legrand A, Yon V. Fourteen-year prospective follow-up study of positive and negative symptoms in chronic schizophrenic patients dying from suicide compared to other causes of death. Psychopathology. 2009;42(3):185–9.

Article  PubMed  Google Scholar 

Sher L, Kahn RS. Suicide in schizophrenia: AN educational overview. Medicina (Kaunas). 2019;55(7).

Bress JN, Arslanoglou E, Banerjee S, Alexopoulos GS, Kiosses DN. Positive valence system function and anhedonia in middle-aged and older adults at high suicide risk. Biol Psychol. 2023;182: 108647.

Article  PubMed  Google Scholar 

Burton TJ, Balleine BW. The positive valence system, adaptive behaviour and the origins of reward. Emerg Top Life Sci. 2022;6(5):501–13.

Article  PubMed  PubMed Central  Google Scholar 

Hasratian AM, Meuret AE, Chmielewski M, Ritz T. An examination of the RDoC negative valence systems domain constructs and the self-reports unit of analysis. Behav Ther. 2022;53(6):1092–108.

Article  PubMed  Google Scholar 

Craske MG, Meuret AE, Ritz T, Treanor M, Dour HJ. Treatment for anhedonia: a neuroscience driven approach. Depress Anxiety. 2016;33(10):927–38.

Article  PubMed  Google Scholar 

Gard DE, Gard MG, Kring AM, John OP. Anticipatory and consummatory components of the experience of pleasure: A scale development study. Journal of Research in Personality. 2006;40(6):1086-1102.

Article  Google Scholar 

Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995;167(1):99–103.

Article  CAS  PubMed  Google Scholar 

Ameli R, Luckenbaugh DA, Gould NF, Holmes MK, Lally N, Ballard ED, et al. SHAPS-C: the Snaith-Hamilton pleasure scale modified for clinician administration. PeerJ. 2014;2: e429.

Article  PubMed  PubMed Central  Google Scholar 

Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.

Article  CAS  PubMed  Google Scholar 

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–13.

Comments (0)

No login
gif